secwatch.observer — SEC 8-K summary
======================================

Issuer:     Erasca, Inc. (ERAS)
CIK:        0001761918
Form:       8-K
Filed at:   2026-04-27T23:59:59+00:00
Accession:  0001193125-26-179214
Event type: litigation
Sentiment:  negative
Materiality: 0.85
Item codes: 7.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Erasca faces patent infringement and trade secret allegations from Revolution Medicines over ERAS-0015
--------------------------------------------------------------------------------

- RevMed alleges ERAS-0015 infringes U.S. Patent No. 12,409,225 and misappropriated trade secrets.
- Erasca believes the allegations are without merit and will vigorously contest them.
- Erasca also announced a conference call at 4:30pm ET today to discuss preliminary Phase 1 data for ERAS-0015.
- No data results were disclosed in this filing; only the call schedule is provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761918/000119312526179214/0001193125-26-179214-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761918/000119312526179214/eras-20260427.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-179214

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer